Chemours Company (CC) Receives a Buy from Barclays


Barclays analyst Duffy Fischer maintained a Buy rating on Chemours Company (CC) yesterday and set a price target of $48. The company’s shares closed yesterday at $33.10.

According to TipRanks.com, Fischer is a 4-star analyst with an average return of 13.1% and a 51.3% success rate. Fischer covers the Consumer Goods sector, focusing on stocks such as Air Products and Chemicals, Sherwin-Williams Company, and Axalta Coating Systems.

Currently, the analyst consensus on Chemours Company is a Strong Buy with an average price target of $44.67, representing a 35.0% upside. In a report issued on January 4, Citigroup also upgraded the stock to Buy with a $35 price target.

See today’s analyst top recommended stocks >>

Based on Chemours Company’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.63 billion and net profit of $275 million. In comparison, last year the company earned revenue of $1.58 billion and had a net profit of $228 million.

Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CC in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts, Chemical Solutions, and Corporate and Other. The Titanium Technologies segment produces titanium dioxide.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts